Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARGX Argenx SE

盘前交易 12-19 05:43:23 EST

847.05

-15.00

-1.74%

盘前851.39

+4.34+0.51%

04:58 EST

最高861.34	最低845.31	成交量24.66万
今开858.35	昨收862.05	日振幅1.86%
总市值518.11亿	流通市值518.11亿	总股本6,117万
成交额2.10亿	换手率0.40%	流通股本6,117万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARGX","market":"US","secType":"STK","nameCN":"Argenx SE","latestPrice":847.05,"timestamp":1766091600000,"preClose":862.05,"halted":0,"volume":246582,"hourTrading":{"tag":"盘前","latestPrice":851.39,"preClose":847.05,"latestTime":"04:58 EST","volume":86,"amount":73166.2544,"timestamp":1766138336305},"delay":0,"floatShares":61166252,"shares":61166252,"eps":23.271248,"marketStatus":"盘前交易","change":-15,"latestTime":"12-19 05:43:23 EST","open":858.345,"high":861.34,"low":845.31,"amount":209723810.3352,"amplitude":0.018595,"askPrice":853.84,"askSize":20,"bidPrice":852.85,"bidSize":20,"shortable":3,"etf":0,"ttmEps":23.271248,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766154600000},"marketStatusCode":1,"adr":1,"adrRate":1,"listingDate":1495080000000,"exchange":"NASDAQ","adjPreClose":847.05,"preHourTrading":{"tag":"盘前","latestPrice":851.39,"preClose":847.05,"latestTime":"04:58 EST","volume":86,"amount":73166.2544,"timestamp":1766138336305},"postHourTrading":{"tag":"盘后","latestPrice":847,"preClose":847.05,"latestTime":"19:54 EST","volume":4887,"amount":4139546.25,"timestamp":1766105679697},"volumeRatio":0.6564148626891182,"impliedVol":0.3378,"impliedVolPercentile":0.4217},"requestUrl":"/m/hq/s/ARGX/tweets","defaultTab":"tweets","newsList":[{"id":"2591436776","title":"明星药物遭重挫！Argenx终止甲状腺眼病药物试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2591436776","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591436776?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:32","pubTimestamp":1765798348,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，比利时生物技术公司Argenx SE表示将终止治疗影响眼睛的自免疫疾病实验药物的后期试验后，其股价创下七个月来最大跌幅。Argenx表示，基于独立数据监测委员会的建议，正在中重度甲状腺眼病成人患者中进行评估的药物Efgartigimod将停止试验。该公司股价在布鲁塞尔股市一度下跌9.7%，为5月8日以来最大跌幅。Argenx预计明年将公布针对多种自免疫疾病的其他四项后期临床试验项目的结果，其中三项涉及Vyvgart。","market":"us","thumbnail":"https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c7da52addfd52fb216bcf87283f43750"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1381720.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"明星药物遭重挫！Argenx终止甲状腺眼病药物试验","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","LU0320765992.SGD","ARGX","BK4585","BK4505","IE0002141913.USD","IE00B4R5TH58.HKD","LU1983260115.SGD","BK4588","LU0109394709.USD","LU2324357040.USD","LU0889565916.HKD","BK4139","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE0009355771.USD","IE0034235188.USD"],"gpt_icon":0},{"id":"2583633533","title":"Argenx Se涨1.03% 股价突破900美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2583633533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583633533?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:52","pubTimestamp":1763131945,"startTime":"0","endTime":"0","summary":"北京时间2025年11月14日22时52分，Argenx Se股票出现异动，股价急速拉升1.03%。Argenx Se股票所在的生物技术行业中，整体涨幅为0.64%。Argenx Se公司简介：Argenx是一家荷兰生物制药公司，专注于开发针对罕见自身免疫性疾病的基于抗体的疗法。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114225226a6f9cd08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251114225226a6f9cd08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0034235188.USD","BK4505","BK4139","IE00BJT1NW94.SGD","LU2324357040.USD","IE0009355771.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0320765992.SGD","BK4588","ARGX","BK4585","IE0002141913.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2574113514","title":"Argenx Se涨0.32% 股价突破800美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2574113514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574113514?lang=zh_cn&edition=full","pubTime":"2025-10-09 21:32","pubTimestamp":1760016729,"startTime":"0","endTime":"0","summary":"北京时间2025年10月09日21时32分，Argenx Se股票出现异动，股价急速拉升0.32%。Argenx Se股票所在的生物技术行业中，整体跌幅为0.15%。Argenx Se公司简介：Argenx是一家荷兰生物制药公司，专注于开发针对罕见自身免疫性疾病的基于抗体的疗法。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213209a6b1f8ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251009213209a6b1f8ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4585","LU0109394709.USD","ARGX","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0889565916.HKD","BK4139","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4588","LU2324357040.USD","BK4505","IE00BJT1NW94.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2558917536","title":"Argenx Se8月11日成交额为4.25亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558917536","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558917536?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:18","pubTimestamp":1754961500,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Argenx Se成交额为4.25亿美元，成交额较昨日增加125.83%，当日成交量为66.25万股。Argenx Se于2025年8月11日跌3.46%，报638.9美元，该股过去5个交易日跌7.45%，年初至今涨3.89%，过去60日涨20.03%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091832a482e303&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812091832a482e303&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4588","LU0109394709.USD","ARGX","BK4139","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE0002141913.USD","LU0889565916.HKD","BK4505","IE00B2B36J28.USD","LU0320765992.SGD","BK4585"],"gpt_icon":0},{"id":"2558508707","title":"Argenx Se8月8日成交额为1.88亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558508707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558508707?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:18","pubTimestamp":1754702305,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Argenx Se成交额为1.88亿美元，成交额较昨日减少15.90%，当日成交量为28.37万股。Argenx Se于2025年8月8日跌1.56%，报661.83美元，该股过去5个交易日跌1.78%，年初至今涨7.61%，过去60日涨22.0%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809091837a47e1c51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809091837a47e1c51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","IE00BJT1NW94.SGD","IE0009355771.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0320765992.SGD","BK4588","ARGX","BK4585","IE0002141913.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2558575425","title":"Argenx Se2025财年第二财季实现净利润4.18亿美元，同比增加1386.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558575425","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558575425?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:00","pubTimestamp":1754668827,"startTime":"0","endTime":"0","summary":"8月9日，Argenx Se公布财报，公告显示公司2025财年第二财季净利润为4.18亿美元，同比增加1386.95%；其中营业收入为17.53亿美元，同比增加99.89%，每股基本收益为6.85美元。从资产负债表来看，Argenx Se总负债10.80亿美元，其中短期债务7.58百万美元，资产负债比为6.65，流动比率为5.60。机构评级：截至2025年8月9日，当前有32家机构对Argenx Se目标价做出预测，其中目标均价为805.07美元，其中最低目标价为700.00美元，最高目标价为1070.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000034a6db5589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000034a6db5589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARGX"],"gpt_icon":0},{"id":"2557581446","title":"Argenx Se8月6日成交额为2.77亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557581446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557581446?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:18","pubTimestamp":1754529505,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Argenx Se成交额为2.77亿美元，成交额较昨日减少14.97%，当日成交量为41.08万股。Argenx Se于2025年8月6日跌0.26%，报673.15美元，该股过去5个交易日涨12.4%，年初至今涨9.46%，过去60日涨22.47%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807091827a6d78e9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807091827a6d78e9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4588","BK4505","BK4139","LU0109394709.USD","BK4585","ARGX"],"gpt_icon":0},{"id":"2557345798","title":"Argenx Se8月5日成交额为3.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557345798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557345798?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:18","pubTimestamp":1754443089,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Argenx Se成交额为3.26亿美元，成交额较昨日增加16.07%，当日成交量为47.63万股。Argenx Se于2025年8月5日跌2.23%，报674.9美元，该股过去5个交易日涨12.71%，年初至今涨9.74%，过去60日涨18.59%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806091812a4778a4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806091812a4778a4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","ARGX","BK4139","BK4588","LU0109394709.USD","BK4505","LU0320765992.SGD"],"gpt_icon":0},{"id":"2557356590","title":"Argenx Se8月4日成交额为2.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557356590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557356590?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:18","pubTimestamp":1754356683,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Argenx Se成交额为2.81亿美元，成交额较昨日减少34.11%，当日成交量为41.10万股。Argenx Se于2025年8月4日涨2.45%，报690.32美元，该股过去5个交易日涨15.98%，年初至今涨12.25%，过去60日涨10.82%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091809a4756520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805091809a4756520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LU0320765992.SGD","BK4585","BK4588","LU0109394709.USD","LU0889565916.HKD","BK4139","ARGX"],"gpt_icon":0},{"id":"2556484478","title":"Argenx Se8月1日成交额为4.26亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556484478","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556484478?lang=zh_cn&edition=full","pubTime":"2025-08-02 09:17","pubTimestamp":1754097473,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Argenx Se成交额为4.26亿美元，成交额较昨日减少54.27%，当日成交量为63.36万股。Argenx Se于2025年8月1日涨0.52%，报673.8美元，该股过去5个交易日涨13.82%，年初至今涨9.56%，过去60日涨9.54%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091755a6ce9d78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802091755a6ce9d78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4588","ARGX","BK4585","LU0109394709.USD","BK4139","BK4505"],"gpt_icon":0},{"id":"2555836637","title":"Argenx Se涨13.04% 股价突破600美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2555836637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555836637?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:31","pubTimestamp":1753968679,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时31分，Argenx Se股票出现异动，股价快速上涨13.04%。Argenx Se股票所在的生物技术行业中，整体涨幅为1.33%。Argenx Se公司简介：Argenx是一家荷兰生物制药公司，专注于开发针对罕见自身免疫性疾病的基于抗体的疗法。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213119a6cbc9c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213119a6cbc9c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4588","BK4505","LU0109394709.USD","LU0320765992.SGD","BK4585","BK4139","ARGX"],"gpt_icon":0},{"id":"2555098994","title":"Argenx Se7月29日成交额为1.57亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555098994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555098994?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:18","pubTimestamp":1753838324,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Argenx Se成交额为1.57亿美元，成交额较昨日减少28.77%，当日成交量为26.37万股。Argenx Se于2025年7月29日涨0.6%，报598.79美元，该股过去5个交易日涨4.82%，年初至今跌2.64%，过去60日跌6.42%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730091856a46a7acf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730091856a46a7acf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LU0109394709.USD","LU0320765992.SGD","BK4588","ARGX","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2555088366","title":"Argenx Se7月28日成交额为2.21亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555088366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555088366?lang=zh_cn&edition=full","pubTime":"2025-07-29 09:18","pubTimestamp":1753751894,"startTime":"0","endTime":"0","summary":"美东时间2025年7月28日，Argenx Se成交额为2.21亿美元，成交额较昨日减少24.24%，当日成交量为37.11万股。Argenx Se于2025年7月28日涨0.54%，报595.19美元，该股过去5个交易日涨5.13%，年初至今跌3.22%，过去60日跌7.74%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091820a4688b94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729091820a4688b94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4505","BK4588","LU0889565916.HKD","ARGX","LU0109394709.USD","BK4585","BK4139"],"gpt_icon":0},{"id":"2554790466","title":"Argenx Se7月25日成交额为2.92亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554790466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554790466?lang=zh_cn&edition=full","pubTime":"2025-07-26 09:18","pubTimestamp":1753492713,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Argenx Se成交额为2.92亿美元，成交额较昨日增加31.92%，当日成交量为49.31万股。Argenx Se于2025年7月25日涨0.04%，报591.99美元，该股过去5个交易日涨4.85%，年初至今跌3.74%，过去60日跌5.96%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726091844a46416ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726091844a46416ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","ARGX","BK4505","LU0889565916.HKD","BK4139","BK4585","LU0109394709.USD","BK4588"],"gpt_icon":0},{"id":"2553221215","title":"Argenx Se7月23日成交额为1.59亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553221215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553221215?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:18","pubTimestamp":1753319880,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Argenx Se成交额为1.59亿美元，成交额较昨日增加24.09%，当日成交量为27.82万股。Argenx Se于2025年7月23日涨0.73%，报575.42美元，该股过去5个交易日跌0.43%，年初至今跌6.44%，过去60日跌6.4%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091810a6be7cfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724091810a6be7cfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","LU0889565916.HKD","BK4585","ARGX","BK4505","LU0109394709.USD","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2553262434","title":"Argenx Se7月22日成交额为1.28亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553262434","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553262434?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:17","pubTimestamp":1753233464,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Argenx Se成交额为1.28亿美元，成交额较昨日增加10.94%，当日成交量为22.47万股。Argenx Se于2025年7月22日涨0.9%，报571.23美元，该股过去5个交易日涨2.75%，年初至今跌7.12%，过去60日跌4.88%。该公司的主要产品Vyvgart 于2021年12月获得FDA批准，用于治疗广泛性重症肌无力。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723091750a6bc011e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723091750a6bc011e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","BK4139","BK4505","ARGX","BK4585","BK4588"],"gpt_icon":0},{"id":"2553400916","title":"Argenx Se7月21日成交额为1.16亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553400916","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553400916?lang=zh_cn&edition=full","pubTime":"2025-07-22 09:17","pubTimestamp":1753147056,"startTime":"0","endTime":"0","summary":"美东时间2025年7月21日，Argenx Se成交额为1.16亿美元，成交额较昨日减少39.53%，当日成交量为20.45万股。Argenx Se于2025年7月21日涨0.27%，报566.14美元，该股过去5个交易日涨0.87%，年初至今跌7.94%，过去60日跌4.79%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722091746a6b96159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250722091746a6b96159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","ARGX","BK4585","BK4505","BK4588","LU0109394709.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2552458325","title":"Argenx Se7月17日成交额为2.57亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458325?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:17","pubTimestamp":1752801459,"startTime":"0","endTime":"0","summary":"美东时间2025年7月17日，Argenx Se成交额为2.57亿美元，成交额较昨日减少3.55%，当日成交量为45.11万股。Argenx Se于2025年7月17日跌0.9%，报572.71美元，该股过去5个交易日涨1.67%，年初至今跌6.88%，过去60日跌3.86%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091742a6b0d3ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718091742a6b0d3ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0889565916.HKD","BK4588","LU0320765992.SGD","BK4139","BK4505","ARGX","LU0109394709.USD"],"gpt_icon":0},{"id":"2552171679","title":"Argenx Se7月16日成交额为2.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552171679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552171679?lang=zh_cn&edition=full","pubTime":"2025-07-17 09:17","pubTimestamp":1752715055,"startTime":"0","endTime":"0","summary":"美东时间2025年7月16日，Argenx Se成交额为2.66亿美元，成交额较昨日增加35.94%，当日成交量为46.47万股。Argenx Se于2025年7月16日涨3.95%，报577.92美元，该股过去5个交易日涨4.09%，年初至今跌6.03%，过去60日跌3.07%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091746a6ae79cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717091746a6ae79cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","BK4139","ARGX","BK4505","BK4588","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2551101134","title":"Argenx Se7月14日成交额为2.01亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551101134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551101134?lang=zh_cn&edition=full","pubTime":"2025-07-15 09:18","pubTimestamp":1752542295,"startTime":"0","endTime":"0","summary":"美东时间2025年7月14日，Argenx Se成交额为2.01亿美元，成交额较昨日增加44.75%，当日成交量为35.63万股。Argenx Se于2025年7月14日涨0.19%，报561.28美元，该股过去5个交易日涨2.79%，年初至今跌8.73%，过去60日跌7.28%。2022年，Argenx还获得了Vyvgart皮下制剂Vyvgart Hytrulo的FDA批准，与Vyvgart的静脉给药相比，这是一种更方便的选择。2024年，FDA批准Vyvgart Hytrulo用于治疗慢性炎症性脱髓鞘多神经病变，这是一种罕见的免疫介导的周围神经系统神经肌肉疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715091822a6a9ceb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715091822a6a9ceb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","BK4505","BK4139","ARGX","BK4588","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.argenx.com","stockEarnings":[{"period":"1week","weight":-0.0477},{"period":"1month","weight":-0.0778},{"period":"3month","weight":0.1497},{"period":"6month","weight":0.5624},{"period":"1year","weight":0.3571},{"period":"ytd","weight":0.3773}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Argenx Se根据荷兰法律于2008年4月25日成立，是一家私人有限责任公司（besloten vennootschap met beperkte aansprakelijkheid）。 于2014年5月28日，根据公证转换契约及修订，该公司转为上市有限责任公司（naamloze vennootschap）。 该公司是一家处于商业阶段的、全球性的、完全整合的生物制药公司，开发用于治疗严重自身免疫性疾病的差异化疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.008981},{"month":2,"riseRate":0.375,"avgChangeRate":0.041314},{"month":3,"riseRate":0.5,"avgChangeRate":-0.018965},{"month":4,"riseRate":0.75,"avgChangeRate":0.033039},{"month":5,"riseRate":0.5,"avgChangeRate":0.060079},{"month":6,"riseRate":0.777778,"avgChangeRate":0.053836},{"month":7,"riseRate":0.666667,"avgChangeRate":0.0867},{"month":8,"riseRate":0.666667,"avgChangeRate":0.01751},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.022149},{"month":10,"riseRate":0.666667,"avgChangeRate":0.037064},{"month":11,"riseRate":0.777778,"avgChangeRate":0.116374},{"month":12,"riseRate":0.444444,"avgChangeRate":0.116767}],"exchange":"NASDAQ","name":"Argenx SE","nameEN":"Argenx SE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Argenx SE,ARGX,Argenx SE股票,Argenx SE股票老虎,Argenx SE股票老虎国际,Argenx SE行情,Argenx SE股票行情,Argenx SE股价,Argenx SE股市,Argenx SE股票价格,Argenx SE股票交易,Argenx SE股票购买,Argenx SE股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Argenx SE(ARGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Argenx SE(ARGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}